Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.07
CBT's Cash to Debt is ranked lower than
67% of the 989 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.68 vs. CBT: 0.07 )
CBT' s 10-Year Cash to Debt Range
Min: 0.02   Max: 1.61
Current: 0.07

0.02
1.61
Equity to Asset 0.45
CBT's Equity to Asset is ranked higher than
51% of the 989 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.56 vs. CBT: 0.45 )
CBT' s 10-Year Equity to Asset Range
Min: 0.34   Max: 0.52
Current: 0.45

0.34
0.52
Interest Coverage 4.24
CBT's Interest Coverage is ranked lower than
56% of the 660 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 16.65 vs. CBT: 4.24 )
CBT' s 10-Year Interest Coverage Range
Min: 3.79   Max: 7.79
Current: 4.24

3.79
7.79
F-Score: 4
Z-Score: 2.60
M-Score: -2.39
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 7.59
CBT's Operating margin (%) is ranked higher than
77% of the 980 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.73 vs. CBT: 7.59 )
CBT' s 10-Year Operating margin (%) Range
Min: -3.62   Max: 15.16
Current: 7.59

-3.62
15.16
Net-margin (%) 4.42
CBT's Net-margin (%) is ranked higher than
71% of the 980 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.76 vs. CBT: 4.42 )
CBT' s 10-Year Net-margin (%) Range
Min: -3.43   Max: 28.78
Current: 4.42

-3.43
28.78
ROE (%) 7.84
CBT's ROE (%) is ranked higher than
75% of the 972 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 6.54 vs. CBT: 7.84 )
CBT' s 10-Year ROE (%) Range
Min: -6.79   Max: 43.27
Current: 7.84

-6.79
43.27
ROA (%) 3.61
CBT's ROA (%) is ranked higher than
70% of the 985 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.38 vs. CBT: 3.61 )
CBT' s 10-Year ROA (%) Range
Min: -2.88   Max: 21.23
Current: 3.61

-2.88
21.23
ROC (Joel Greenblatt) (%) 10.78
CBT's ROC (Joel Greenblatt) (%) is ranked higher than
69% of the 981 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 10.91 vs. CBT: 10.78 )
CBT' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -5.08   Max: 28.93
Current: 10.78

-5.08
28.93
Revenue Growth (%) 8.30
CBT's Revenue Growth (%) is ranked higher than
75% of the 789 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.20 vs. CBT: 8.30 )
CBT' s 10-Year Revenue Growth (%) Range
Min: -50.2   Max: 103.7
Current: 8.3

-50.2
103.7
EBITDA Growth (%) 9.30
CBT's EBITDA Growth (%) is ranked higher than
78% of the 681 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 4.20 vs. CBT: 9.30 )
CBT' s 10-Year EBITDA Growth (%) Range
Min: -53.8   Max: 109.5
Current: 9.3

-53.8
109.5
EPS Growth (%) 6.10
CBT's EPS Growth (%) is ranked higher than
72% of the 630 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.40 vs. CBT: 6.10 )
CBT' s 10-Year EPS Growth (%) Range
Min: -22.9   Max: 27.4
Current: 6.1

-22.9
27.4
» CBT's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

CBT Guru Trades in Q1 2013

Paul Tudor Jones 19,700 sh (+286.27%)
Chuck Royce 3,052,430 sh (+11.95%)
PRIMECAP Management 1,010,000 sh (unchged)
Paul Singer 460,000 sh (unchged)
David Dreman 746,188 sh (-0.91%)
Jim Simons 29,300 sh (-89.69%)
» More
Q2 2013

CBT Guru Trades in Q2 2013

PRIMECAP Management 1,010,000 sh (unchged)
Jim Simons Sold Out
Chuck Royce 3,039,700 sh (-0.42%)
David Dreman 651,472 sh (-12.69%)
Paul Tudor Jones 7,900 sh (-59.9%)
» More
Q3 2013

CBT Guru Trades in Q3 2013

Chuck Royce 3,041,200 sh (+0.05%)
PRIMECAP Management 1,010,000 sh (unchged)
Paul Tudor Jones Sold Out
David Dreman 184,380 sh (-71.7%)
» More
Q4 2013

CBT Guru Trades in Q4 2013

Paul Tudor Jones 4,300 sh (New)
Jim Simons 33,100 sh (New)
David Dreman 210,759 sh (+14.31%)
Chuck Royce 3,143,593 sh (+3.37%)
PRIMECAP Management 1,010,000 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with CBT

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
David Dreman 2013-09-30 Reduce -71.7%0.57%$37.61 - $42.97 $ 59.1146%184380
Joel Greenblatt 2012-12-31 Sold Out 0.12%$33.72 - $40.17 $ 59.1159%0
David Dreman 2012-12-31 Add 15.27%0.11%$33.72 - $40.17 $ 59.1159%753018
Joel Greenblatt 2012-09-30 New Buy0.12%$34.54 - $41.29 $ 59.1156%49573
PRIMECAP Management 2012-09-30 Add 25.32%0.01%$34.54 - $41.29 $ 59.1156%990000
PRIMECAP Management 2012-06-30 New Buy0.05%$35.55 - $44.66 $ 59.1148%790000
Ray Dalio 2011-12-31 Sold Out 0.05%$23.27 - $34 $ 59.1196%0
David Dreman 2011-09-30 New Buy0.45%$24.88 - $42.8 $ 59.1170%727754
George Soros 2011-06-30 Sold Out $37.45 - $47.83 $ 59.1140%0
George Soros 2011-03-31 Reduce -85.87%0.06%$37.65 - $46.58 $ 59.1137%9100
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 18.00
CBT's P/E(ttm) is ranked higher than
66% of the 808 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 18.60 vs. CBT: 18.00 )
CBT' s 10-Year P/E(ttm) Range
Min: 5.62   Max: 122.58
Current: 18

5.62
122.58
P/B 1.80
CBT's P/B is ranked higher than
56% of the 960 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.59 vs. CBT: 1.80 )
CBT' s 10-Year P/B Range
Min: 0.47   Max: 2.55
Current: 1.8

0.47
2.55
P/S 1.10
CBT's P/S is ranked higher than
54% of the 1000 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.95 vs. CBT: 1.10 )
CBT' s 10-Year P/S Range
Min: 0.19   Max: 1.45
Current: 1.1

0.19
1.45
PFCF 18.40
CBT's PFCF is ranked higher than
64% of the 489 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 18.82 vs. CBT: 18.40 )
CBT' s 10-Year PFCF Range
Min: 2.13   Max: 115.06
Current: 18.4

2.13
115.06
EV-to-EBIT 18.20
CBT's EV-to-EBIT is ranked higher than
53% of the 842 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 14.88 vs. CBT: 18.20 )
CBT' s 10-Year EV-to-EBIT Range
Min: 8.4   Max: 54.7
Current: 18.2

8.4
54.7
PEG 0.50
CBT's PEG is ranked higher than
94% of the 499 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.51 vs. CBT: 0.50 )
CBT' s 10-Year PEG Range
Min: 0.46   Max: 33.99
Current: 0.5

0.46
33.99
Shiller P/E 22.90
CBT's Shiller P/E is ranked higher than
62% of the 442 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 22.21 vs. CBT: 22.90 )
CBT' s 10-Year Shiller P/E Range
Min: 9.48   Max: 50.39
Current: 22.9

9.48
50.39

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.40
CBT's Dividend Yield is ranked lower than
58% of the 755 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.80 vs. CBT: 1.40 )
CBT' s 10-Year Dividend Yield Range
Min: 1.35   Max: 8.83
Current: 1.4

1.35
8.83
Dividend Payout 0.25
CBT's Dividend Payout is ranked higher than
71% of the 638 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.33 vs. CBT: 0.25 )
CBT' s 10-Year Dividend Payout Range
Min: 0.02   Max: 3
Current: 0.25

0.02
3
Dividend growth (3y) 3.60
CBT's Dividend growth (3y) is ranked higher than
67% of the 431 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 10.40 vs. CBT: 3.60 )
CBT' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 11.9
Current: 3.6

0
11.9
Yield on cost (5-Year) 1.60
CBT's Yield on cost (5-Year) is ranked lower than
59% of the 771 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 2.03 vs. CBT: 1.60 )
CBT' s 10-Year Yield on cost (5-Year) Range
Min: 1.54   Max: 10.09
Current: 1.6

1.54
10.09
Share Buyback Rate -0.10
CBT's Share Buyback Rate is ranked higher than
77% of the 567 Companies
in the Global Specialty Chemicals industry.

( Industry Median: -1.00 vs. CBT: -0.10 )
CBT' s 10-Year Share Buyback Rate Range
Min: 55.2   Max: -113.4
Current: -0.1

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 3.50
CBT's Price/Tangible Book is ranked lower than
64% of the 927 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.70 vs. CBT: 3.50 )
CBT' s 10-Year Price/Tangible Book Range
Min: 0.62   Max: 3.05
Current: 3.5

0.62
3.05
Price/DCF (Projected) 1.50
CBT's Price/DCF (Projected) is ranked higher than
64% of the 432 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.40 vs. CBT: 1.50 )
CBT' s 10-Year Price/DCF (Projected) Range
Min: 0.31   Max: 3.44
Current: 1.5

0.31
3.44
Price/Median PS Value 1.20
CBT's Price/Median PS Value is ranked lower than
57% of the 927 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.00 vs. CBT: 1.20 )
CBT' s 10-Year Price/Median PS Value Range
Min: 0.27   Max: 1.99
Current: 1.2

0.27
1.99
Price/Peter Lynch Fair Value 0.70
CBT's Price/Peter Lynch Fair Value is ranked higher than
82% of the 234 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.10 vs. CBT: 0.70 )
CBT' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.55   Max: 4.09
Current: 0.7

0.55
4.09
Price/Graham Number 1.60
CBT's Price/Graham Number is ranked lower than
52% of the 779 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.30 vs. CBT: 1.60 )
CBT' s 10-Year Price/Graham Number Range
Min: 0.61   Max: 2.56
Current: 1.6

0.61
2.56
Earnings Yield (Greenblatt) 5.50
CBT's Earnings Yield (Greenblatt) is ranked higher than
59% of the 886 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 6.60 vs. CBT: 5.50 )
CBT' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.8   Max: 11.9
Current: 5.5

1.8
11.9
Forward Rate of Return (Yacktman) 34.41
CBT's Forward Rate of Return (Yacktman) is ranked higher than
97% of the 594 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 6.16 vs. CBT: 34.41 )
CBT' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -19.7   Max: 35.2
Current: 34.41

-19.7
35.2

Business Description

Industry: Chemicals » Specialty Chemicals
Compare:NEU, SCL, VAL, POL, CYT » details
Traded in other countries:CBT.Germany
Cabot Corporation was founded in 1882 and was incorporated in the State of Delaware in 1960. Cabot is a global specialty chemicals and performance materials Company. Its products are rubber and specialty grade carbon blacks, fumed metal oxides, tantalum and related products, inkjet colorants, aerogels and cesium formate drilling fluids. Cabot and its affiliates have manufacturing facilities and operations in the United States and approximately 20 other countries. It is organized into four business segments: the Core Segment; the Performance Segment; the New Business Segment and the Specialty Fluids Segment. For operational purposes, the Company is also organized into three geographic regions: The Americas, which includes North and South America; Europe, Middle East and Africa and Asia Pacific, including China. The Core Segment is comprised of the Rubber Blacks Business and the Supermetals Business. Rubber black's products are used in tires and industrial products. In industrial products such as hoses, belts, extruded profiles and molded goods.The raw material used in the manufacture of carbon black is a portion of the residual heavy oils derived from petroleum refining operations and from the distillation of coal tars and the production of ethylrene thoughout the world. It operates plants that produce rubber blacks in Argentina, Brazil, Canada, China, Colombia, the Czech Republic, France, India, Indonesia, Italy, Japan, Malaysia, The Netherlands, and the United States. Supermetals Business produces tantalum, niobium (columbium) and its alloys. Electronics is the largest application for tantalum powder, which is used to make capacitors for computers, networking devices, wireless phones, electronics for automobiles and other devices. The Company operates manufacturing facilities for this business in Boyertown, Pennsylvania and Kawahigashi-machi, Japan. The Performance Segment is comprised of two product lines: specialty grades of carbon black and thermoplastic concentrates; and fumed silica, fumed alumina and dispersions thereof. These products are used in applications, such as inks, coatings, cables, pipes, toners and electronics. The raw material used in the manufacture of carbon black is a portion of the residual heavy oils derived from petroleum refining operations and from the distillation of coal tars and the production of ethylene throughout the world. It operates plants that produce specialty grades of carbon black in China, The Netherlands and the United States. New Business Segment includes the Inkjet Colorants and Aerogel Businesses, and the business development activities of Cabot Superior Micropowders. Raw materials for inkjet colorants include carbon black sourced from its carbon black plants, organic pigments and other treating agents available from different sources. Cabot's aerogel is a nano-structured, high surface area, hydrophobic, silica-based particle that is used in thermal insulation and specialty chemical a

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide